SENOF (Sensorion) Change In Other Working Capital : $-2.63 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sensorion Change In Other Working Capital?

Sensorion's Change In Other Working Capital for the quarter that ended in Dec. 2024 was $-7.19 Mil. It means Sensorion's Other Working Capital declined by $7.19 Mil from Jun. 2024 to Dec. 2024 .

Sensorion's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-2.75 Mil. It means Sensorion's Other Working Capital declined by $2.75 Mil from Dec. 2023 to Dec. 2024 .

Sensorion Change In Other Working Capital Historical Data

The historical data trend for Sensorion's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensorion Change In Other Working Capital Chart

Sensorion Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

1.39

6.52

2.65

3.49

-2.75

Sensorion Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Other Working Capital	Get a 7-Day Free Trial															0.38	1.55	1.93	4.56	-7.19

Sensorion Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.63 Mil.

Sensorion Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Sensorion's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensorion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sensorion SA (OTCPK:SENOF) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

ALSEN:France RFM:Germany

Address

375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080

Website

https://www.sensorion.com/en

Sensorion SA is a France-based clinical-stage biotech company dedicated to developing therapies to restore, treat, and prevent hearing loss. The company's product is in phase 2a clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies. The Company does business in a single operating segment: conducting research and development to discover drugs to treat inner ear disorders with a view to their future marketing. The company's pipeline programs are SENS-401 SSNHL, SENS-401 CIO, GJB2-GT, GJB2-GT, SENS-401 Cochlear, and others.